Yuhan Corporation (KRX:000100)
South Korea · Delayed Price · Currency is KRW 87,000
+5,000 (6.10%)
Aug 11, 2026, 10:10 AM KST
Yuhan Market Cap
Yuhan has a market cap or net worth of 6.11 trillion as of August 10, 2026. Its market cap has decreased by -28.64% in one year.
Market Cap
6.11T
Enterprise Value
6.11T
Revenue
2.22T
Ranking
n/a
PE Ratio
29.24
Stock Price
87,000.00
ChartMarket Cap Chart
Since April 26, 2001, Yuhan's market cap has increased from 231.73B to 6.11T, an increase of 2,538.46%. That is a compound annual growth rate of 13.81%.
| Date | Market Cap | % Change |
|---|---|---|
| Aug 7, 2026 | 6.01T | -28.38% |
| Dec 30, 2025 | 8.39T | -6.18% |
| Dec 30, 2024 | 8.94T | 73.59% |
| Dec 28, 2023 | 5.15T | 25.86% |
| Dec 29, 2022 | 4.09T | -3.94% |
| Dec 30, 2021 | 4.26T | -9.20% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Hanmi Pharm. | 4.98T |
| Hanall Biopharma | 2.75T |
| Celltrion Pharm | 1.95T |
| Daewoong Pharmaceutical | 1.48T |
| GC Biopharma | 1.48T |
| Chong Kun Dang Pharmaceutical | 928.91B |
| DongKook Pharmaceutical | 870.64B |
| Daewoong | 754.14B |